FORM 8-K

Company

Carisma Therapeutics Inc.

Filed

June 23, 2025

Period of Report

June 22, 2025

Accession Number

0001104659-25-061397

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →